Annals of internal medicine
-
Multicenter Study
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States.
Cost-effectiveness analysis is an important tool for informing treatment coverage and pricing decisions, yet no consensus exists about what threshold for the incremental cost-effectiveness ratio (ICER) in dollars per quality-adjusted life-year (QALY) gained indicates whether treatments are likely to be cost-effective in the United States. ⋯ None.
-
Editorial Multicenter Study
Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults.
Coronavirus disease 2019 (COVID-19) has rapidly instigated a global pandemic. Vaccine development is proceeding at an unprecedented pace. Once available, it will be important to maximize vaccine uptake and coverage. ⋯ Agency for Healthcare Research and Quality.
-
Multicenter Study
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building.
The role of fecal aerosols in the transmission of severe acute respiratory syndrome coronavirus 2 has been suspected. ⋯ Key-Area Research and Development Program of Guangdong Province and the Research Grants Council of Hong Kong.
-
Multicenter Study Comparative Study
Low-dose chest CT had 95% sensitivity and 91% specificity for diagnosing COVID-19 in patients with clinical symptoms.
Schulze-Hagen M, Hübel C, Meier-Schroers M, et al. Low-dose chest CT for the diagnosis of COVID-19. Dtsch Arztebl Int. 2020;117:389-95. 32762834.
-
Randomized Controlled Trial Multicenter Study
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial.
No effective oral therapy exists for early coronavirus disease 2019 (COVID-19). ⋯ Private donors.